Should I buy or sell Silk Road Medical stock right now?

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last twelve months. There are currently 2 sell ratings, 5 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" SILK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SILK, but not buy additional shares or sell existing shares. View SILK analyst ratings or view top-rated stocks .

What is Silk Road Medical's stock price target for 2024?

11 brokerages have issued 1-year price targets for Silk Road Medical's shares. Their SILK share price targets range from $8.00 to $47.00. On average, they expect the company's stock price to reach $22.18 in the next twelve months. This suggests a possible upside of 27.3% from the stock's current price. View analysts price targets for SILK or view top-rated stocks among Wall Street analysts .

How have SILK shares performed in 2024?

Silk Road Medical's stock was trading at $12.27 at the beginning of 2024. Since then, SILK shares have increased by 42.0% and is now trading at $17.42. View the best growth stocks for 2024 here .

When is Silk Road Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 30th 2024. View our SILK earnings forecast .

How can I listen to Silk Road Medical's earnings call?

Silk Road Medical will be holding an earnings conference call on Tuesday, April 30th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link .

How were Silk Road Medical's earnings last quarter?

Silk Road Medical, Inc (NASDAQ:SILK) posted its earnings results on Wednesday, February, 28th. The company reported ($0.33) EPS for the quarter, topping the consensus estimate of ($0.40) by $0.07. The business had revenue of $47.27 million for the quarter, compared to the consensus estimate of $42.23 million. Silk Road Medical had a negative trailing twelve-month return on equity of 36.38% and a negative net margin of 31.70%.

What ETFs hold Silk Road Medical's stock?

ETFs with the largest weight of Silk Road Medical (NASDAQ:SILK) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE) , Invesco Dorsey Wright Healthcare Momentum ETF (PTH) and American Century Focused Dynamic Growth ETF (FDG) . iShares U.S. Medical Devices ETF (IHI) .

What guidance has Silk Road Medical issued on next quarter's earnings?

Silk Road Medical issued an update on its FY 2024 earnings guidance on Wednesday, February, 28th. The company provided EPS guidance of for the period. The company issued revenue guidance of $194.0 million-$198.0 million, compared to the consensus revenue estimate of $191.7 million.

What other stocks do shareholders of Silk Road Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include RTX (RTX) , Procter & Gamble (PG) , Abbott Laboratories (ABT) , Cisco Systems (CSCO) , Pfizer (PFE) , Edwards Lifesciences (EW) , CSX (CSX) , Thermo Fisher Scientific (TMO) and Alibaba Group (BABA) .

When did Silk Road Medical IPO?

Silk Road Medical (SILK) raised $75 million in an IPO on Thursday, April 4th 2019. The company issued 4,700,000 shares at $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.

How do I buy shares of Silk Road Medical?

Shares of SILK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:SILK

Silk Road Medical (SILK) Stock Price, News & Analysis

→ Start loving Mondays like this (From DTI) (Ad)

Free SILK Stock Alerts

$17.42

-0.04 (-0.23%)

(As of 04:23 PM ET)

Compare

Today's Range: $17.30
▼
$18.00
50-Day Range: $15.48
▼
$19.12
52-Week Range: $6.08
▼
$46.57

Volume: 291,738 shs
Average Volume: 803,886 shs
Market Capitalization: $682.34 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $22.18

Get Silk Road Medical alerts:

Silk Road Medical MarketRank™ Stock Analysis

Analyst Rating: Hold
2.18 Rating Score
Upside/Downside: 27.3% Upside
$22.18 Price Target
Short Interest: Bearish
10.44% of Shares Sold Short
Dividend Strength: N/A
Sustainability: -0.74
Upright™ Environmental Score
News Sentiment: 0.74
Based on 4 Articles This Week
Insider Trading: Selling Shares
$351,247 Sold Last Quarter
Proj. Earnings Growth: Growing
From ($1.39) to ($1.29) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.41 out of 5 stars

Medical Sector

278th out of 919 stocks

Surgical & Medical Instruments Industry

31st out of 93 stocks

3.1

Analyst's Opinion

Consensus Rating
Silk Road Medical has received a consensus rating of Hold. The company's average rating score is 2.18, and is based on 4 buy ratings, 5 hold ratings, and 2 sell ratings.
Amount of Analyst Coverage
Silk Road Medical has only been the subject of 4 research reports in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
10.44% of the outstanding shares of Silk Road Medical have been sold short.
Short Interest Ratio / Days to Cover
Silk Road Medical has a short interest ratio ("days to cover") of 4.8.
Change versus previous month
Short interest in Silk Road Medical has recently increased by 9.95%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Silk Road Medical does not currently pay a dividend.
Dividend Growth
Silk Road Medical does not have a long track record of dividend growth.

4.3

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Silk Road Medical has received a 62.88% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Surgical instruments" and "Medical devices engineering" products. See details.
Environmental Sustainability
The Environmental Impact score for Silk Road Medical is -0.74.

2.6

News and Social Media Coverage

News Sentiment
Silk Road Medical has a news sentiment score of 0.74. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for Silk Road Medical this week, compared to 3 articles on an average week.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Silk Road Medical insiders have sold 76.70% more of their company's stock than they have bought. Specifically, they have bought $198,783.00 in company stock and sold $351,247.00 in company stock.
Percentage Held by Insiders
Only 6.70% of the stock of Silk Road Medical is held by insiders.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Silk Road Medical are expected to grow in the coming year, from ($1.39) to ($1.29) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Silk Road Medical is -12.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Silk Road Medical is -12.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Silk Road Medical has a P/B Ratio of 4.49. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Crypto 101 Media

[Urgent!] Generational Wealth Gameplan

A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.

Click here to get instant access to the guide

About Silk Road Medical Stock (NASDAQ:SILK)

Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.

SILK Stock Price History

30 days | 90 days | 365 days | Advanced Chart

SILK Stock News Headlines

April 13, 2024 | americanbankingnews.com

Silk Road Medical (NASDAQ:SILK) Shares Up 3.5%

April 12, 2024 | americanbankingnews.com

Silk Road Medical, Inc (NASDAQ:SILK) Receives Average Rating of "Hold" from Analysts

April 18, 2024 | Priority Gold (Ad)

Biden to Launch “FedNOW” [Move Your Money Now]

Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...

April 9, 2024 | globenewswire.com

Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024

April 5, 2024 | msn.com

Taiwan Earthquake: What to Know About Travel and How to Help

April 3, 2024 | finance.yahoo.com

Worker injured by electric shock from power line in Biddeford

April 3, 2024 | msn.com

April 2, 2024 | globenewswire.com

Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS

April 18, 2024 | Paradigm Press (Ad)

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

March 28, 2024 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: PAVmed (PAVM) and Simulations Plus (SLP)

March 15, 2024 | finance.yahoo.com

SILK Oct 2024 25.000 call

March 15, 2024 | finance.yahoo.com

SILK Jul 2024 25.000 call

March 11, 2024 | yahoo.com

Why now’s the time to discover Uzbekistan – before it turns into Dubai

March 7, 2024 | msn.com

Argus upgrades Silk Road Medical to buy, cites expanding footprint

March 7, 2024 | realmoney.thestreet.com

Argus gets more bullish on Silk Road Medical, upgrades shares

March 7, 2024 | realmoney.thestreet.com

Argus upgrades Silk Road Medical to Buy amid expanding commercial footprint

March 7, 2024 | finance.yahoo.com

Silk Road Medical, Inc: Upgrading to BUY with a target of $24

March 7, 2024 | msn.com

Silk Road Medical's (SILK) New Stent Expands Its TCAR Portfolio

March 5, 2024 | globenewswire.com

Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System

March 2, 2024 | finance.yahoo.com

Silk Road Medical, Inc (NASDAQ:SILK) Released Earnings Last Week And Analysts Lifted Their Price Target To US$18.43

March 1, 2024 | finance.yahoo.com

Silk Road Medical Full Year 2023 Earnings: Beats Expectations

February 29, 2024 | markets.businessinsider.com

Breaking Down Silk Road Medical: 5 Analysts Share Their Views

February 29, 2024 | markets.businessinsider.com

Analysts Conflicted on These Healthcare Names: Castle Biosciences (CSTL), DENTSPLY SIRONA (XRAY) and Silk Road Medical (SILK)

February 29, 2024 | finance.yahoo.com

Silk Road Medical, Inc (NASDAQ:SILK) Q4 2023 Earnings Call Transcript

February 29, 2024 | finance.yahoo.com

Q4 2023 Silk Road Medical Inc Earnings Call

February 28, 2024 | benzinga.com

Silk Road Medical: Q4 Earnings Insights

February 28, 2024 | markets.businessinsider.com

Silk Road Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Financial Outlook

See More Headlines

Receive SILK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/28/2024
Today: 4/18/2024
Next Earnings (Confirmed): 4/30/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: NASDAQ:SILK
CUSIP: N/A
CIK: 1397702
Web: www.silkroadmed.com
Phone: (408) 720-9002
Fax: 408-720-9013
Employees: 474
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $22.18
High Stock Price Target: $47.00
Low Stock Price Target: $8.00
Potential Upside/Downside: +23.9%
Consensus Rating: Hold
Rating Score (0-4): 2.18
Research Coverage: 11 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.44)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-55,740,000.00
Net Margins: -31.70%
Pretax Margin: -31.47%
Return on Equity: -36.38%
Return on Assets: -21.41%

Debt

Debt-to-Equity Ratio: 0.50
Current Ratio: 7.95
Quick Ratio: 6.97

Sales & Book Value

Annual Sales: $177.13 million
Price / Sales: 3.96
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $3.88 per share
Price / Book: 4.62

Miscellaneous

Outstanding Shares: 39,170,000
Free Float: 36,550,000
Market Cap: $701.53 million
Optionable: Optionable
Beta: 1.48

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

Mr. Lucas W. Buchanan (Age 46)
CFO & COO
Comp: $870.55k
Mr. Kevin M. Klemz (Age 63)
EVP, Chief Legal Officer & Secretary
Comp: $644.12k
Mr. Andrew S. Davis (Age 55)
Chief Commercial Officer
Comp: $836.33k
Mr. Richard M. Ruedy (Age 57)
Executive Vice President of Clinical, Regulatory Affairs & Quality Assurance
Comp: $542.41k
Mr. Charles S. McKhann (Age 55)
Chief Executive Officer
Ms. Mhairi L. Jones (Age 53)
Chief Accounting Officer & VP of Finance
Ms. Tammy Leitsinger
Compliance Officer & VP of Medical Affairs
Mr. Jorge O'Hara
Vice President of Marketing, Business Development & Strategy
Ms. Alison Highlander
Vice President of Human Resources
Dr. Sumaira MacDonald M.D.
Ph.D., Executive Medical Director

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

SILK Stock Analysis - Frequently Asked Questions

Should I buy or sell Silk Road Medical stock right now?: 11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last twelve months. There are currently 2 sell ratings, 5 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" SILK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SILK, but not buy additional shares or sell existing shares.
View SILK analyst ratings or view top-rated stocks.
What is Silk Road Medical's stock price target for 2024?: 11 brokerages have issued 1-year price targets for Silk Road Medical's shares. Their SILK share price targets range from $8.00 to $47.00. On average, they expect the company's stock price to reach $22.18 in the next twelve months. This suggests a possible upside of 27.3% from the stock's current price.
View analysts price targets for SILK or view top-rated stocks among Wall Street analysts.
How have SILK shares performed in 2024?: Silk Road Medical's stock was trading at $12.27 at the beginning of 2024. Since then, SILK shares have increased by 42.0% and is now trading at $17.42.
View the best growth stocks for 2024 here.
When is Silk Road Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 30th 2024.
View our SILK earnings forecast.
How can I listen to Silk Road Medical's earnings call?: Silk Road Medical will be holding an earnings conference call on Tuesday, April 30th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.
How were Silk Road Medical's earnings last quarter?: Silk Road Medical, Inc (NASDAQ:SILK) posted its earnings results on Wednesday, February, 28th. The company reported ($0.33) EPS for the quarter, topping the consensus estimate of ($0.40) by $0.07. The business had revenue of $47.27 million for the quarter, compared to the consensus estimate of $42.23 million. Silk Road Medical had a negative trailing twelve-month return on equity of 36.38% and a negative net margin of 31.70%.

What ETFs hold Silk Road Medical's stock?: ETFs with the largest weight of Silk Road Medical (NASDAQ:SILK) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE), Invesco Dorsey Wright Healthcare Momentum ETF (PTH) and American Century Focused Dynamic Growth ETF (FDG).iShares U.S. Medical Devices ETF (IHI).
What guidance has Silk Road Medical issued on next quarter's earnings?: Silk Road Medical issued an update on its FY 2024 earnings guidance on Wednesday, February, 28th. The company provided EPS guidance of for the period. The company issued revenue guidance of $194.0 million-$198.0 million, compared to the consensus revenue estimate of $191.7 million.
What other stocks do shareholders of Silk Road Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include RTX (RTX), Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW), CSX (CSX), Thermo Fisher Scientific (TMO) and Alibaba Group (BABA).
When did Silk Road Medical IPO?: Silk Road Medical (SILK) raised $75 million in an IPO on Thursday, April 4th 2019. The company issued 4,700,000 shares at $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.
How do I buy shares of Silk Road Medical?: Shares of SILK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SILK) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial